Dr. Nora Khaldi is the Founder and Chief Scientific Officer of Nuritas, a company helping to solve some of the greatest challenges in biology and medicine. She has a PhD in Molecular Evolution and Bioinformatics as well as a Master’s in Mathematics. Dr. Khaldi is disrupting the status quo of drug discovery by integrating artificial intelligence (AI) and big data to extract peptides from natural sources for the development of therapies to address a broad range of health areas. She has a unique interdisciplinary background in Mathematics, Bioinformatics and Molecular Biology. Nora was the first scientist to show gene transfer between multi-cellular species. This ground-breaking find put into question many of the phylogenetic methods currently in use today. Some of Nora’s publications have been placed in a library of the top 2% of published articles in the fields of biology and medicine. Starting from an idea at her kitchen table and initially funded by personal savings, Dr Khaldi has grown Nuritas rapidly surrounding herself with a team of experts and raising funding from numerous sources in excess of $65m. She also spearheaded the expansion of Nuritas to the USA with the opening of a Boston office. Dr Khaldi has been recognised with numerous awards for her innovation and entrepreneurship. Of note, she was named Woman of the Decade in Business and Leadership at the Women Economic Forum (WEF) European Union Event and received the Rising Star prize form the Tech Excellence Awards in 2017. In 2019 she was inducted into the Young Global Leaders, the World Economic Forum’s foundation for remarkable leaders under 40. Dr. Khaldi continues to lead the Nuritas team in their goal of reaching billions of people with their life-changing ingredients, working with global leaders such as Nestle and BASF to achieve this.